Angiopoietin-2 is vasoprotective in the acute phase of cerebral ischemia

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 3, 2013, Pages 389-395

  Marteau, Léna ^a,b,c   Valable, Samuel ^a,b,c   Divoux, Didier ^a,b,c   Roussel, Simon A ^a,b,c   Touzani, Omar ^a,b,c   MacKenzie, Eric T ^a,b,c   Bernaudin, Myriam ^a,b,c   Petit, Edwige ^a,b,c  

^a CNRS   (France)

^b UNIVERSITÉ DE CAEN   (France)

^c DIF   (France)

Author keywords

angiopoietins; blood brain barrier; ischemia; MRI; vascular permeability; VEGF

Indexed keywords

ANGIOPOIETIN 2; NEUROPROTECTIVE AGENT; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; IN VIVO STUDY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANGIOPOIETIN-2; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CAPILLARY PERMEABILITY; GENE EXPRESSION REGULATION; MAGNETIC RESONANCE ANGIOGRAPHY; MICE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84874662945     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2012.178     Document Type: Article

References (40)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012; 125: e2-e220.
2. Suwanwela N, Koroshetz WJ. Acute ischemic stroke: overview of recent therapeutic developments. Annu Rev Med 2007; 58: 89-106.
3. Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E et al. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 2000; 156: 965-976.
4. Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 1994; 25: 1794-1798.
5. Ding G, Jiang Q, Li L, Zhang L, Zhang ZG, Ledbetter KA et al. Angiogenesis detected after embolic stroke in rat brain using magnetic resonance T2*WI Stroke 2008; 39: 1563-1568.
6. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 439-442.
7. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435-439.
8. Valable S, Montaner J, Bellail A, Berezowski V, Brillault J, Cecchelli R et al. VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1. J Cereb Blood Flow Metab 2005; 25: 1491-1504.
9. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 2000; 106: 829-838.
10. Kim KL, Shin I, Kim J, Choi J, Byun J, Jeon E et al. Interaction between Tie receptors modulates angiogenic activity of angiopoietin2 in endothelial progenitor cells. Cardiovasc Res 2006; 72: 394-402.
11. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996; 87: 1161-1169.
12. Mandriota SJ, Pepper MS. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res 1998; 83: 852-859.
13. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55-60.
14. Daly C, Pasnikowski E, Burova E, Wong V, Aldrich TH, Griffiths J et al. Angiopoietin-functions as an autocrine protective factor in stressed endothelial cells. Proc Natl Acad Sci USA 2006; 103: 15491-15496.
15. Eklund L, Olsen BR. Tie receptors and their angiopoietin ligands are contextdependent regulators of vascular remodeling. Exp Cell Res 2006; 312: 630-641.
16. Roviezzo F, Tsigkos S, Kotanidou A, Bucci M, Brancaleone V, Cirino G et al. Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Ther 2005; 314: 738-744.
17. Zhu Y, Lee C, Shen F, Du R, Young WL, Yang G. Angiopoietin-2 facilitates vascular endothelial growth factor-induced angiogenesis in the mature mouse brain. Stroke 2005; 36: 1533-1537.
18. Valable S, Eddi D, Constans J, Guillamo J, Bernaudin M, Roussel S et al. MRI assessment of hemodynamic effects of angiopoietin-2 overexpression in a brain tumor model. Neuro Oncol 2009; 11: 488-502.
19. Zacchigna S, Lambrechts D, Carmeliet P. Neurovascular signalling defects in neurodegeneration. Nat Rev Neurosci 2008; 9: 169-181.
20. Ward NL, LaManna JC. The neurovascular unit and its growth factors: coordinated response in the vascular and nervous systems. Neurol Res 2004; 26: 870-883.
21. Liu XS, Chopp M, Zhang RL, Hozeska-Solgot A, Gregg SC, Buller B et al. Angiopoietin 2 mediates the differentiation and migration of neural progenitor cells in the subventricular zone after stroke. J Biol Chem 2009; 284: 22680-22689.
22. Androutsellis-Theotokis A, Rueger MA, Park DM, Mkhikian H, Korb E, Poser SW et al. Targeting neural precursors in the adult brain rescues injured dopamine neurons. Proc Natl Acad Sci USA 2009; 106: 13570-13575.
23. Androutsellis-Theotokis A, Rueger MA, Park DM, Boyd JD, Padmanabhan R, Campanati L et al. Angiogenic factors stimulate growth of adult neural stem cells. PLoS One 2010; 5: e9414.
24. Marteau L, Pacary E, Valable S, Bernaudin M, Guillemot F, Petit E. Angiopoietin-2 regulates cortical neurogenesis in the developing telencephalon. Cereb Cortex 2011; 21: 1695-1702.
25. Welsh FA, Sakamoto T, McKee AE, Sims RE. Effect of lactacidosis on pyridine nucleotide stability during ischemia in mouse brain. J Neurochem1987; 49: 846-851.
26. Valable S, Bellail A, Lesné S, Liot G, Mackenzie ET, Vivien D et al. Angiopoietin-1-induced phosphatidyl-inositol 3-kinase activation prevents neuronal apoptosis. FASEB J 2003; 17: 443-445.
27. Rosa AI, Gonçalves J, Cortes L, Bernardino L, Malva JO, Agasse F. The angiogenic factor angiopoietin-1 is a proneurogenic peptide on subventricular zone stem/progenitor cells. J Neurosci 2010; 30: 4573-4584.
28. Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and timps are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998; 29: 2189-2195.
29. Beck H, Acker T, Wiessner C, Allegrini PR. Plate KH. Expression of angiopoietin-1, angiopoietin-2, and tie receptors after middle cerebral artery occlusion in the rat. Am J Pathol 2000; 157: 1473-1483.
30. Hayashi T, Noshita N, Sugawara T, Chan PH. Temporal profile of angiogenesis and expression of related genes in the brain after ischemia. J Cereb Blood Flow Metab 2003; 23: 166-180.
31. Wang Y, Jin K, Mao XO, Xie L, Banwait S, Marti HH et al. VEGF-overexpressing transgenic mice show enhanced post-ischemic neurogenesis and neuromigration. J Neurosci Res 2007; 85: 740-747.
32. Lee S, Kim WJ, Jun H, Choi YK, Kim K. Angiopoietin-1 reduces vascular endothelial growth factor-induced brain endothelial permeability via upregulation of ZO-2. Int J Mol Med 2009; 23: 279-284.
33. Zhao Y, Li Z, Wang R, Wei J, Li G, Zhao H. Angiopoietin 1 counteracts vascular endothelial growth factor-induced blood-brain barrier permeability and alleviates ischemic injury in the early stages of transient focal cerebral ischemia in rats. Neurol Res 2010; 32: 748-755.
34. Chae S, Kamoun WS, Farrar CT, Kirkpatrick ND, Niemeyer E, de Graaf AMA et al. Angiopoietin-2 interferes with anti-VEGFR2-induced vessel normalization and survival benefit in mice bearing gliomas. Clin Cancer Res 2010; 16: 3618-3627.
35. Felcht M, Luck R, Schering A, Seidel P, Srivastava K, Hu J et al. Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling. J Clin Invest 2012; 122: 1991-2005.
36. PietiläR, Nätynki M, Tammela T, Kangas J, Pulkki KH, Limaye N et al. Ligand oligomerization state controlsTie2 receptor trafficking and angiopoietin-2-specific responses. J Cell Sci 2012; 125: 2212-2223.
37. Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci USA 2009; 106: 1977-1982.
38. Cai J, Wu L, Qi X, Shaw L, Li Calzi S, Caballero S et al. Placenta growth factor-1 exerts time-dependent stabilization of adherens junctions following VEGFinduced vascular permeability. PLoS One 2011; 6: e18076.
39. Bai Y, Meng Z, Cui M, Zhang X, Chen F, Xiao J et al. An Ang1-Tie2-PI3K axis in neural progenitor cells initiates survival responses against oxygen and glucose deprivation. Neuroscience 2009; 160: 371-381.
40. Kim I, Kim JH, Moon SO, Kwak HJ, Kim NG, Koh GY. Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Oncogene 2000; 19: 4549-4552.